Victor Cortes
Head, Research OneChain Immunotherapeutics
With more than 15 years in biomedical and oncological research at the Autonomous University of Barcelona, the Hospital de la Vall d’Hebron, the New York University School of Medicine and the San Raffaele Biomedical Science Park in Milan, and the IMIM-Hospital del Mar. After completing his postdoctoral training, he joined the Universitat Pompeu Fabra as a full professor and later as an assistant, and has recently joined the International University of Catalonia.
Seminars
Thursday 3rd December 2026
Applying Reverse Translation to Improve Predictive Models for Next Generation CAR-T Development
1:10 pm
- Using clinical learnings from advanced ex vivo CAR-T programmes to identify limitations in existing preclinical models and improve future model design
- Understanding how efficacy, persistence, resistance, and safety observations can be translated back into preclinical systems to strengthen development strategies
- Creating continuous feedback loops between clinical, translational, and preclinical teams to improve confidence in ex vivo and in vivo CAR-T progression decisions
Thursday 3rd December 2026
Panel Discussion: What Evidence Gives Us Confidence That a Model Will Translate?
1:50 pm
- How can clinical observations and reverse translational insights be used to improve future model development and regulatory confidence?
- What role should patient-derived and human-relevant tumour models play in identifying novel targets and improving candidate selection?
- Which biological, translational, or clinical endpoints provide the strongest evidence that a programme is ready for progression?
- Audience Q&As
